Vise Technologies’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Buy
4,718
+1,591
+51% +$106K ﹤0.01% 1418
2026
Q1
$208K Hold
3,127
– – ﹤0.01% 1362
2025
Q4
$208K Buy
+3,127
New +$202K ﹤0.01% 1373
2025
Q3
– Sell
-2,627
Closed -$229K – 1192
2025
Q2
$229K Buy
+2,627
New +$206K 0.01% 944

Other funds holding DXCM

Vise Technologies's DXCM Position: Q2 2026 in Review

Vise Technologies increased its DexCom (DXCM) stake by 51% in Q2 2026, buying an estimated $106K and bringing the position to 4,718 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

Vise Technologies first reported a position in DXCM in Q2 2025 and has held it in 4 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Vise Technologies held 4,718 shares of DexCom worth $318K as of Q2 2026.
  • Vise Technologies bought 1,591 DexCom shares in Q2 2026, an estimated $106K.
  • DexCom made up ﹤0.01% of Vise Technologies's portfolio in Q2 2026, its #1418 holding.
  • Vise Technologies first reported a position in DexCom in Q2 2025 and has held it in 4 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.